Skip to main content
Alexander Kutikov, MD, Urology, Philadelphia, PA

Alexander Kutikov MD FACS

Minimally Invasive Surgery, Surgical Oncology


Co-Executive Director, Fox Chase - Temple Urologic Institute Chair, Fox Chase Cancer Center Department of Urology Roberta R. Scheller Endowed Chair in Urologic Oncology Professor, Fox Chase Cancer Center Professor, Lewis Katz School of Medicine, Temple University

Join to View Full Profile
  • 333 Cottman AvenueFox Chase Cancer CenterPhiladelphia, PA 19111

  • Phone+1 215-728-6900

  • Fax+1 215-214-1734

Dr. Kutikov is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Alexander Kutikov, MD, FACS, is Co-Executive Director of the Fox Chase–Temple Urologic Institute and Chair of the Department of Urology at Fox Chase Cancer Center in Philadelphia, where he holds the Roberta R. Scheller Endowed Chair in Urologic Oncology. A board-certified urologic surgical oncologist, he leads one of the Northeast’s busiest urology and urologic oncology practices, specializing in robotic, laparoscopic, and complex open surgery for genitourinary cancers.

    An internationally recognized academic surgeon, Dr. Kutikov has authored more than 300 peer-reviewed publications, including the widely adopted R.E.N.A.L. Nephrometry Score for kidney tumors. Under his leadership, the Fox Chase Urology group expanded into a full Department and helped form the Fox Chase–Temple Urologic Institute, contributing to the program’s rise into the top 20 in Urology rankings by U.S. News & World Report.

    Dr. Kutikov trained in the Harvard–MIT Health Sciences and Technology Program at Harvard Medical School, completed residency at the University of Pennsylvania, and fellowship training in urologic oncology at Fox Chase Cancer Center.
  • My Bibliography - My NCBI Collection

Education & Training

  • Fox Chase Cancer Center
    Fox Chase Cancer CenterFellowship, Urologic Surgical Oncology, 2008 - 2010
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemChief Residency, Urology, 2007 - 2008
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Urology, 2004 - 2007
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemInternship, Urology, 2003 - 2004
  • Harvard Medical School
    Harvard Medical SchoolClass of 2003

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2009 - 2027
  • PA State Medical License
    PA State Medical License 2003 - 2026
  • Urology
    American Board of Urology Urology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Assessment of Volume Preservation Performed Before or After Partial Nephrectomy Accurately Predicts Postoperative Renal Function: Results from a Prospective Multicente...  
    Alexander Kutikov, Robert G Uzzo, Brian R Lane, Urologic Oncology
  • Genomic Copy Number Alterations in Renal Cell Carcinoma with Sarcomatoid Features  
    Richard E Greenberg, Rosalia Viterbo, Timothy Ito, Marc C Smaldone, Joseph R Testa, Philip H Abbosh, Robert G Uzzo, Alexander Kutikov, The Journal of Urology
  • Testicular Compartment Syndrome: A New Approach to Conceptualizing and Managing Testicular Torsion.  
    Kutikov A, Casale P, White MA, Mayer WA, Chang A, Gozalbez R, Canning DA., Urology

Books/Book Chapters

Abstracts/Posters

  • mTOR pathway activation in primary renal cell carcinoma and match metastases.
    Kutikov A, Egleston BL, Morrison T, Henske EP, Huang M, Al-Saleem T, Uzzo RG., American Urological Association Meeting, Chicago, IL
  • Routine Adrenalectomy is Unnecessary During Surgery for Renal Cell Carcinoma – Event for Large and/or Upper Pole Tumors.
    Kutikov A, Piotrowski Z, Canter DJ, Kister DL, Litwin S, Chen DYT, Viterbo R, Greenberg RE, Boorjian SA, Uzzo RG., American Urological Association Meeting, San Fransisco, CA
  • Anatomical Features of Enhancing Renal Masses Predict Histology and Grade – an Analysis Using Nephrometry.
    Kutikov A, Manley BJ, Canter DJ, Egleston BL, Kister DL, Chen DYT, Greenberg RE, Boorjian SA, Viterbo R, Uzzo RG., American Urological Association Meeting, San Francisco, CA

Lectures

  • Management of Adrenal Incidentaloma in the Patient with Cancer. 
    Temple University General Surgery Grand Rounds
  • Moderator for Podium Session on Urologic Oncology. 
    Mid-Atlantic New England AUA Sectional Meeting, Orlando, FL
  • Adrenal Mass in the Cancer Patient. 
    University of Pennsylvania Urology Grand Rounds

Authored Content

  • The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: A Real World Multi-Institutional AnalysisFebruary 2022

Press Mentions

  • Global Burden of Renal Cancer Expected to Double by 2050
    Global Burden of Renal Cancer Expected to Double by 2050October 21st, 2025
  • Kidney Cancer Cases Are Expected to Double by 2050, Study Finds
    Kidney Cancer Cases Are Expected to Double by 2050, Study FindsSeptember 30th, 2025
  • Kidney Cancer Cases to Double by 2050: 5 Warning Signs You Should Not Ignore
    Kidney Cancer Cases to Double by 2050: 5 Warning Signs You Should Not IgnoreSeptember 29th, 2025

Professional Memberships

Other Languages

  • Russian

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: